Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 18, 2022 - Issue 5
Submit an article Journal homepage
3,498
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial

Christian Schwabea Auckland Clinical Studies Ltd, Auckland, New ZealandView further author information
,
Andras Illesb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandCorrespondence[email protected]
View further author information
,
Martin Ullmannb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
,
Vishal Ghorib Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
,
Emmanuelle Vincentb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
,
Corinne Petit-Frereb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
,
Joelle Monnetb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
,
Anne Sophie Racaultb Biosimilars, Fresenius Kabi SwissBioSim, Eysins, SwitzerlandView further author information
&
Chris Wynnec Christchurch Clinical Studies Trust Ltd, New ZealandView further author information
 show all
Pages 533-543 | Received 22 Dec 2021, Accepted 28 Mar 2022, Published online: 10 Apr 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.